KAYLA WEBSTER: Open Payments
NPI 1831666726 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 45 payments from 14 companies in 2025. Trend: 2023 $1,556 · 2024 $977 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 10 | $335 |
| Merck Sharp & Dohme LLC | 6 | $188 |
| Abbott Laboratories | 7 | $136 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| United Therapeutics Corporation | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $52 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: GVOKE HYPOPEN, WINREVAIR, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Tyvaso, VERQUVO, WAINUA, ONPATTRO, OPSYNVI.
Industry payments across OK — which companies pay providers there.
